Lan Nguyen, M.D.

  • Assistant Professor of Pediatrics 
  • Director, Adult Congenital Heart Disease

Christina Nguyen focuses her research in the areas of transplant outcomes, the transition of care between pediatric and adult medicine, and infectious complications
in kidney transplantation. She is the director of the 

Pediatric Kidney Transplant Program. She serves as a
site sub-investigator in two multicenter, NIH-funded research projects in the eld of transplantation. She is a co-investigator for an internal grant with the Hillman Foundation looking at neurocognitive outcomes in very young recipients of kidney transplants. She serves as the site principal investigator in two pharmaceutical trials and a co-investigator on one other pharmaceutical trial. Active projects include outcomes and epidemiology of donor- speci c antibodies in pediatric kidney transplantation, a case series on the use of bortezomib to treat acute antibody- mediated rejection, and strati cation of pre-transplant psychosocial risk factors that are associated with high-risk post-transplant behaviors in kidney transplant recipients.

Major Lectureships and Seminars

  • “Adult Congenital Heart Disease- A Focus on Pulmonary Stenosis and Tetralogy of Fallot,” Three Rivers Echo Society, Canonsburgh, Pa., May 2016
  • “The Adult Patient with Congenital Heart Disease II: The Operated Patient,” Three Rivers Echo Society, Canonsburg, Pa., May 2015

Professional Affiliations/Society Memberships

  • Adult Congenital Heart Association
  • American Society of Echocardiography

Education & Training

  • MD: University of Texas Southwestern Medical Center Dallas, TX
  • Residency: Barnes-Jewish Hospital St Louis, MO
  • Fellowship: University of Pittsburgh School of Medicine Pittsburgh, PA
  • Fellowship: University of Pittsburgh School of Medicine Pittsburgh, PA

Research Interests

Urinary Biomarkers in Young Adults with Congenital Heart Disease is an ongoing collaborative research project with the Center for Critical Care Nephrology to compare levels of urinary biomarkers of kidney injury and dysfunction in healthy young adults and young adults with congenital heart disease. The primary goal of this study is to establish an objective method to quantify renal fitness in young adult congenital heart disease (CHD) patients, a growing population that is at risk for numerous kidney insults across a lifetime